NO20043988L - Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner - Google Patents

Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner

Info

Publication number
NO20043988L
NO20043988L NO20043988A NO20043988A NO20043988L NO 20043988 L NO20043988 L NO 20043988L NO 20043988 A NO20043988 A NO 20043988A NO 20043988 A NO20043988 A NO 20043988A NO 20043988 L NO20043988 L NO 20043988L
Authority
NO
Norway
Prior art keywords
chiral
preparation
substituted piperazines
piperazines
substituted
Prior art date
Application number
NO20043988A
Other languages
English (en)
Norwegian (no)
Inventor
Gregg Brian Feigelson
Joseph Zeldis
Ivo Jirkovsky
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20043988L publication Critical patent/NO20043988L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/06Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing halogen atoms, or nitro or nitroso groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
NO20043988A 2002-03-12 2004-09-23 Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner NO20043988L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36345802P 2002-03-12 2002-03-12
PCT/US2003/007176 WO2003078420A2 (en) 2002-03-12 2003-03-10 Process for making chiral 1,4-disubstituted piperazines

Publications (1)

Publication Number Publication Date
NO20043988L true NO20043988L (no) 2004-09-23

Family

ID=28041772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043988A NO20043988L (no) 2002-03-12 2004-09-23 Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner

Country Status (20)

Country Link
US (3) US7019137B2 (es)
EP (1) EP1483256A2 (es)
JP (1) JP2005527530A (es)
KR (1) KR20040091119A (es)
CN (2) CN100451014C (es)
AR (1) AR038931A1 (es)
AU (1) AU2003220110B2 (es)
BR (1) BR0308347A (es)
CA (1) CA2477906A1 (es)
CR (1) CR7428A (es)
EC (1) ECSP045292A (es)
IL (1) IL163828A0 (es)
MX (1) MXPA04008730A (es)
NO (1) NO20043988L (es)
NZ (1) NZ535169A (es)
RU (2) RU2315044C2 (es)
TW (1) TW200304825A (es)
UA (1) UA79774C2 (es)
WO (1) WO2003078420A2 (es)
ZA (1) ZA200408205B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
CN100451014C (zh) * 2002-03-12 2009-01-14 惠氏公司 制备手性1,4-二取代哌嗪的方法
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
PA8626301A1 (es) * 2004-03-19 2006-12-07 Wyeth Wyeth Proceso para preparar derivados de n-aril-piperazina
EP2896624B1 (en) 2007-03-28 2016-07-13 Atir Holding S.A. Heterotricyclic compounds as serotonergic and/or dopaminergic agents and uses thereof
CN108627380B (zh) * 2017-03-15 2020-10-20 中国人民解放军军事医学科学院毒物药物研究所 去除或减少有毒物质的方法以及检测有毒物质的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE960203C (de) * 1953-12-25 1957-03-21 Yoshitomi Pharmaceutical Verfahren zur Herstellung von N-substituierten Aminocarbonsaeureestern
ZA848005B (en) * 1983-10-17 1985-05-29 Duphar Int Res Blood-pressure lowering piperazine derivatives
ATE81975T1 (de) 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
AU645681B2 (en) 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
JP3367104B2 (ja) * 1992-04-13 2003-01-14 藤沢薬品工業株式会社 抗菌剤としての置換された3−ピロリジニルチオ−カルバペネム化合物
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds
JP3077047B2 (ja) 1993-04-16 2000-08-14 参天製薬株式会社 新規ピペラジン誘導体
WO1995033725A1 (en) 1994-06-03 1995-12-14 John Wyeth & Brother Limited Novel processes and intermediates for the preparation of piperazine derivatives
GB9411099D0 (en) 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9413772D0 (en) 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
ES2201105T3 (es) * 1994-08-05 2004-03-16 Pfizer Inc. Derivados del bencimidazol con actividad dopaminergica.
US5681958A (en) * 1995-06-07 1997-10-28 Shaman Pharmaceuticals, Inc. Cryptolepine analogs with hypoglycemic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
GB9514901D0 (en) 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
DE69716900T2 (de) 1996-04-10 2003-07-03 Merck & Co., Inc. Alpha v Beta 3 ANTAGONISTEN
US6271234B1 (en) * 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
JPH11106381A (ja) * 1997-09-30 1999-04-20 Ss Pharmaceut Co Ltd クロメン誘導体及びその塩並びにこれを含有する医薬
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents
US6875772B2 (en) * 2001-11-30 2005-04-05 Schering Corporation [1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists
CN100341854C (zh) * 2002-03-12 2007-10-10 惠氏公司 制备n1-(2’-吡啶基)-1,2-丙烷二胺氨基磺酸的方法及其用于合成生物活性哌嗪
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
BR0308377A (pt) * 2002-03-12 2005-01-11 Wyeth Corp Processo para sìntese de n-aril piperazinas quirais
CN100451014C (zh) * 2002-03-12 2009-01-14 惠氏公司 制备手性1,4-二取代哌嗪的方法
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution

Also Published As

Publication number Publication date
AR038931A1 (es) 2005-02-02
AU2003220110A1 (en) 2003-09-29
IL163828A0 (en) 2005-12-18
RU2007125687A (ru) 2009-01-20
US7019137B2 (en) 2006-03-28
RU2315044C2 (ru) 2008-01-20
UA79774C2 (en) 2007-07-25
TW200304825A (en) 2003-10-16
BR0308347A (pt) 2005-01-25
WO2003078420A3 (en) 2004-03-11
CN101492383A (zh) 2009-07-29
JP2005527530A (ja) 2005-09-15
NZ535169A (en) 2006-03-31
KR20040091119A (ko) 2004-10-27
EP1483256A2 (en) 2004-12-08
US20080058543A1 (en) 2008-03-06
MXPA04008730A (es) 2004-12-06
CN1642937A (zh) 2005-07-20
US7256289B2 (en) 2007-08-14
ZA200408205B (en) 2007-03-28
WO2003078420A2 (en) 2003-09-25
CN100451014C (zh) 2009-01-14
US20030208075A1 (en) 2003-11-06
CA2477906A1 (en) 2003-09-25
US20050228181A1 (en) 2005-10-13
CR7428A (es) 2008-09-23
AU2003220110B2 (en) 2009-04-09
ECSP045292A (es) 2004-10-26
RU2004130313A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
NO20052262D0 (no) Fremgangsmate til fremstilling av 4-substituerte 2,2,6,6-tetrametyl-piperidin-N-oksy- og 2,2,6,6-tetrametyl-piperidin-N-hydroksy-forbindelser
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
NO20021559D0 (no) Fremgangsmåte til gjenvinning av ammoniakk
IL172542A0 (en) 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
NO20033433L (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20031754D0 (no) Fremgangsmåte for fremstilling av mesylater av piperzinderivater
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
NO20043988L (no) Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20041224L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20034597L (no) Fremgangsmate for fremstilling av cantaxantin
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
EP1598657A4 (en) METHOD FOR DETERMINING THE ABSOLUTE CONFIGURATION OF CHIRAL COMPOUNDS
ITMI20011205A0 (it) Processo integrato di produzione di 2,6 dimetilfaftalene
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application